Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Miso Robotics CEO Rich Hull discusses Flippy Fry Station, the future of AI-powered restaurant automation and how acquiring Zume's IP could reshape food robotics
After two years of AI-fueled spending, Wall Street is asking what's next. Gil Luria breaks down monetization, valuations, winners, losers, and AI's future.